Pharma companies don’t have to comply. Large pharmaceutical companies are notoriously risk averse when it comes to expanding access to medications that are still in the testing phase. Many refuse to grant access to investigational drugs outside of clinical trials, and efforts to lobby them to release the medication as part of compassionate use are often rebuffed

Quick Read

The new law has a catchy name, but it will only make it more difficult to know if medication is effective or safe

Quick Read

Our Gail Javitt writes, “The reality is that Right to Try is unlikely meaningfully to increase the number of terminally ill patients who can access investigational therapies or improve the outcomes for such patients. Those that claim otherwise, and who cast FDA as the primary obstacle between dying patients and lifesaving medicines, are peddling their own form of ‘snake-oil'”

Quick Read

In a grim layering of American tragedies, a 67-year-old man with a lung disease was able to crowdfund his medical treatment only after his wife died in the Santa Fe, Tex., school shooting

Quick Read

He still ended up with a $7,924 bill. You can’t avoid surprise medical bills even with a “PhD in surprise billing.”

Quick Read

One patient’s death changed the course of Dr. Lilia Cervantes’ career. The patient, Cervantes says, was a woman from Mexico with kidney failure who repeatedly visited the emergency room for more than three years

Quick Read

When you need pricey dental care. For millions of Americans — blessed in some measure with good genes and good luck — dental insurance works pretty well, and they don’t think much about it

Quick Read

Be the first to like. Like Unlike 0

Quick Read